180 related articles for article (PubMed ID: 12803233)
1. Octreotide-sensitive ectopic ACTH production by islet cell carcinoma with multiple liver metastases.
Doi M; Imai T; Shichiri M; Tateno T; Fukai N; Ozawa N; Sato R; Teramoto K; Hirata Y
Endocr J; 2003 Apr; 50(2):135-43. PubMed ID: 12803233
[TBL] [Abstract][Full Text] [Related]
2. A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases.
Kondo T; Matsuyama R; Ashihara H; Matsuo Y; Sasaki K; Goto R; Ono K; Takaki Y; Honda Y; Iyama K; Kawashima J; Motoshima H; Tsuruzoe K; Miyamura N; Araki E
Endocr J; 2010; 57(3):229-36. PubMed ID: 20032567
[TBL] [Abstract][Full Text] [Related]
3. Carcinoid-associated ectopic ACTH syndrome with variable response to octreotide.
Gill GV; Yong A; Power E; Ramage J
Postgrad Med J; 1999 Feb; 75(880):98-100. PubMed ID: 10448471
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole.
Kim DS; Park SK; Choi WH; Kim TW; Choi YY; Jeon SC; Ryu JS
Exp Clin Endocrinol Diabetes; 2000; 108(2):146-50. PubMed ID: 10826524
[TBL] [Abstract][Full Text] [Related]
5. A case of ectopic ACTH syndrome associated with Zollinger-Ellison syndrome: long-term survival with chemical adrenalectomy.
Ishido H; Yamashita N; Kitaoka M; Tanaka Y; Ogata E
Endocr J; 1994 Apr; 41(2):171-6. PubMed ID: 7951565
[TBL] [Abstract][Full Text] [Related]
6. [Case of pancreatic endocrine tumor associated with Cushing's syndrome].
Ohno Y; Sakai T; Miyata T
Nihon Shokakibyo Gakkai Zasshi; 2007 Oct; 104(10):1526-32. PubMed ID: 17917402
[TBL] [Abstract][Full Text] [Related]
7. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
8. Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma.
Tsukamoto E; Kanegae K; Itoh K; Okushiba S; Ohno K; Katoh H; Tamaki N
Ann Nucl Med; 1996 Aug; 10(3):339-42. PubMed ID: 8883711
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide.
Bertagna X; Favrod-Coune C; Escourolle H; Beuzeboc P; Christoforov B; Girard F; Luton JP
J Clin Endocrinol Metab; 1989 May; 68(5):988-91. PubMed ID: 2565915
[TBL] [Abstract][Full Text] [Related]
10. Adrenocorticotropic hormone--secreting islet cell tumors: are they always malignant?
Doppman JL; Nieman LK; Cutler GB; Chrousos GP; Fraker DL; Norton JA; Jensen RT
Radiology; 1994 Jan; 190(1):59-64. PubMed ID: 8259429
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production.
Tadokoro R; Sato S; Otsuka F; Ueno M; Ohkawa S; Katakami H; Taniyama M; Nagasaka S
Intern Med; 2016; 55(20):2979-2983. PubMed ID: 27746436
[TBL] [Abstract][Full Text] [Related]
12. Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide.
Rodrigues P; Castedo JL; Damasceno M; Carvalho D
Arq Bras Endocrinol Metabol; 2012 Oct; 56(7):461-4. PubMed ID: 23108752
[TBL] [Abstract][Full Text] [Related]
13. Octreotide in control of multiple liver metastases from gastrinoma.
Saijo F; Naito H; Funayama Y; Fukushima K; Shibata C; Hashimoto A; Kitayama T; Nagao M; Matsuno S; Sasaki I
J Gastroenterol; 2003; 38(9):905-8. PubMed ID: 14564638
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome.
Tabarin A; Valli N; Chanson P; Bachelot Y; Rohmer V; Bex-Bachellerie V; Catargi B; Roger P; Laurent F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1193-202. PubMed ID: 10199752
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.
De Rosa G; Testa A; Liberale I; Pirronti T; Granone P; Picciocchi A
Exp Clin Endocrinol; 1993; 101(5):319-25. PubMed ID: 8299710
[TBL] [Abstract][Full Text] [Related]
17. Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life.
Coe SG; Tan WW; Fox TP
J Gen Intern Med; 2008 Jun; 23(6):875-8. PubMed ID: 18386102
[TBL] [Abstract][Full Text] [Related]
18. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.
Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J
BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720
[TBL] [Abstract][Full Text] [Related]
20. High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report.
Mehta R; Lam-Chung CE; Hinojosa-Amaya JM; Roldán-Sarmiento P; Guillen-Placencia MF; Villanueva-Rodriguez G; Juarez-Leon OA; Leon-Domínguez J; Grajales-Gómez M; Ventura-Gallegos JL; León-Suárez A; Gómez-Pérez FJ; Cuevas-Ramos D
Front Endocrinol (Lausanne); 2020; 11():557. PubMed ID: 32903471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
